Galapagos NV (GLPG)
USD 27.34
(2.09%)
USD 27.34
(2.09%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 239.7 Million EUR | -51.4% |
| 2022 | 493.2 Million EUR | 2.07% |
| 2021 | 483.21 Million EUR | 1159.36% |
| 2020 | -45.61 Million EUR | -110.92% |
| 2019 | 417.66 Million EUR | 1326.99% |
| 2018 | -34.04 Million EUR | 62.76% |
| 2017 | -91.41 Million EUR | -808.97% |
| 2016 | -10.05 Million EUR | 88.84% |
| 2015 | -90.15 Million EUR | -115.97% |
| 2014 | -41.74 Million EUR | -143.3% |
| 2013 | 96.4 Million EUR | 9.43% |
| 2012 | 88.09 Million EUR | 402.73% |
| 2011 | -29.09 Million EUR | -555.1% |
| 2010 | 6.39 Million EUR | -19.99% |
| 2009 | 7.99 Million EUR | -83.76% |
| 2008 | 49.2 Million EUR | 37.57% |
| 2007 | 35.77 Million EUR | 129.02% |
| 2006 | 15.61 Million EUR | 143.63% |
| 2005 | 6.41 Million EUR | -1.2% |
| 2004 | 6.48 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 61.31 Million EUR | 2.39% |
| 2024 Q1 | 59.88 Million EUR | 120.4% |
| 2023 Q3 | 114.32 Million EUR | -21.52% |
| 2023 Q4 | -293.55 Million EUR | -356.76% |
| 2023 Q2 | 145.68 Million EUR | -16.89% |
| 2023 Q1 | 175.29 Million EUR | 92.68% |
| 2023 FY | 239.7 Million EUR | -51.4% |
| 2022 FY | 493.2 Million EUR | 2.07% |
| 2022 Q4 | 90.97 Million EUR | -32.01% |
| 2022 Q1 | 133.43 Million EUR | -19.63% |
| 2022 Q2 | 134.97 Million EUR | 1.15% |
| 2022 Q3 | 133.81 Million EUR | -0.86% |
| 2021 Q2 | 813 Thousand EUR | 105.05% |
| 2021 Q1 | -16.1 Million EUR | -223.93% |
| 2021 Q3 | 63.66 Million EUR | 7730.87% |
| 2021 Q4 | 166.01 Million EUR | 160.77% |
| 2021 FY | 483.21 Million EUR | 1159.36% |
| 2020 FY | -45.61 Million EUR | -110.92% |
| 2020 Q4 | 12.99 Million EUR | 3046.94% |
| 2020 Q3 | -441 Thousand EUR | 99.03% |
| 2020 Q2 | -45.51 Million EUR | -144.82% |
| 2020 Q1 | -18.59 Million EUR | -89.59% |
| 2019 Q2 | -35.63 Million EUR | 28.94% |
| 2019 FY | 417.66 Million EUR | 1326.99% |
| 2019 Q3 | 513.25 Million EUR | 1540.35% |
| 2019 Q4 | -9.8 Million EUR | -101.91% |
| 2019 Q1 | -50.14 Million EUR | -428.6% |
| 2018 FY | -34.04 Million EUR | 62.76% |
| 2018 Q4 | 15.26 Million EUR | 4.81% |
| 2018 Q3 | 14.56 Million EUR | 145.49% |
| 2018 Q2 | -32 Million EUR | -0.46% |
| 2018 Q1 | -31.85 Million EUR | -5.98% |
| 2017 Q1 | -10.93 Million EUR | -129.82% |
| 2017 Q2 | -21.05 Million EUR | -92.45% |
| 2017 Q4 | -30.06 Million EUR | -2.36% |
| 2017 Q3 | -29.36 Million EUR | -39.52% |
| 2017 FY | -91.41 Million EUR | -808.97% |
| 2016 Q1 | -17.69 Million EUR | 31.0% |
| 2016 FY | -10.05 Million EUR | 88.84% |
| 2016 Q3 | -23.11 Million EUR | -290.51% |
| 2016 Q2 | -5.91 Million EUR | 66.56% |
| 2016 Q4 | 36.67 Million EUR | 258.67% |
| 2015 Q1 | -16.77 Million EUR | -22.75% |
| 2015 Q3 | -27.88 Million EUR | -40.51% |
| 2015 Q4 | -25.64 Million EUR | 8.02% |
| 2015 FY | -90.15 Million EUR | -115.97% |
| 2015 Q2 | -19.84 Million EUR | -18.32% |
| 2014 Q2 | -3.87 Million EUR | 0.0% |
| 2014 Q4 | -13.66 Million EUR | -27.39% |
| 2014 Q3 | -10.72 Million EUR | -176.76% |
| 2014 Q1 | -3.87 Million EUR | -188.58% |
| 2014 FY | -41.74 Million EUR | -143.3% |
| 2013 Q1 | 7.51 Million EUR | 115.41% |
| 2013 Q4 | 4.37 Million EUR | 0.0% |
| 2013 Q3 | 4.37 Million EUR | -41.82% |
| 2013 Q2 | 7.51 Million EUR | 0.0% |
| 2013 FY | 96.4 Million EUR | 9.43% |
| 2012 FY | 88.09 Million EUR | 402.73% |
| 2012 Q4 | -48.8 Million EUR | -566.64% |
| 2012 Q3 | 10.45 Million EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2011 FY | -29.09 Million EUR | -555.1% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2010 FY | 6.39 Million EUR | -19.99% |
| 2010 Q4 | - EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 FY | 7.99 Million EUR | -83.76% |
| 2009 Q4 | - EUR | 0.0% |
| 2009 Q2 | - EUR | 0.0% |
| 2008 FY | 49.2 Million EUR | 37.57% |
| 2008 Q4 | - EUR | 0.0% |
| 2007 FY | 35.77 Million EUR | 129.02% |
| 2006 FY | 15.61 Million EUR | 143.63% |
| 2005 FY | 6.41 Million EUR | -1.2% |
| 2004 FY | 6.48 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 247213.402% |
| Psyence Biomedical Ltd. | -240.00 USD | 99875100.0% |
| XOMA Corporation | 3.86 Million USD | -6108.236% |
| Mesoblast Limited | -9.81 Million USD | 2542.18% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -77.202% |
| Aptorum Group Limited | -1.11 Million USD | 21603.775% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 5332691.769% |
| HilleVax, Inc. | -2.15 Million USD | 11217.811% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3477.008% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 869.066% |
| Precision BioSciences, Inc. | 40.47 Million USD | -492.261% |
| Dyadic International, Inc. | 922.95 Thousand USD | -25870.874% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 163161.224% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 325.87% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1038.123% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -56433.019% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -479.181% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -153.054% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2859.295% |
| IGM Biosciences, Inc. | -211.66 Million USD | 213.248% |
| Opthea Limited | 21.72 Thousand USD | -1103491.16% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -59526.866% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -9743.943% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -7818.731% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -100.162% |
| NextCure, Inc. | -3.68 Million USD | 6606.515% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1894.451% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 19994.097% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1095.392% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -54.854% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 344.051% |
| Senti Biosciences, Inc. | -2.68 Million USD | 9034.029% |
| Apollomics, Inc. | 127 Thousand USD | -188640.157% |
| PureTech Health plc | -1.6 Million USD | 15053.213% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 927.465% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -29787.781% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 316.945% |
| ChromaDex Corporation | 50.78 Million USD | -372.036% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -98.964% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 628.847% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 3929.073% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 344.186% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -199650.0% |
| Fortress Biotech, Inc. | 57.85 Million USD | -314.326% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 651.504% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1042273.913% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -184284.615% |
| Celcuity Inc. | -142.77 Thousand USD | 167990.062% |
| ContextLogic Inc. | 59 Million USD | -306.271% |
| GH Research PLC | -315 Thousand USD | 76195.238% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1345.979% |
| Cassava Sciences, Inc. | -89.42 Million USD | 368.052% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -61519.537% |
| ImmuCell Corporation | 4.39 Million USD | -5352.332% |
| Amarin Corporation plc | 165.54 Million USD | -44.798% |
| TG Therapeutics, Inc. | 219.1 Million USD | -9.398% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 12109.018% |
| Acelyrin, Inc. | -115 Thousand USD | 208534.783% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -3311.129% |
| Novavax, Inc. | 639.93 Million USD | 62.543% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -46443.689% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 92.947% |
| AnaptysBio, Inc. | 14.78 Million USD | -1521.676% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 42375.132% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 19169.212% |
| AbCellera Biologics Inc. | 38.02 Million USD | -530.375% |
| CorMedix Inc. | -205.56 Thousand USD | 116707.155% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -880.328% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3473.369% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 97.879% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 50611.543% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2304907.692% |
| Soligenix, Inc. | 97.31 Thousand USD | -246223.643% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2317.596% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 0.43% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 46486.426% |
| Kura Oncology, Inc. | -849 Thousand USD | 28333.216% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 6850.211% |
| Ardelyx, Inc. | 106.66 Million USD | -124.731% |
| Ainos, Inc. | -253.73 Thousand USD | 94569.383% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 457.207% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Prothena Corporation plc | -129.2 Million USD | 285.525% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -142.026% |
| Autolus Therapeutics plc | -4.86 Million USD | 5025.005% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -375.369% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 142778.571% |
| Celularity Inc. | 6.75 Million USD | -3448.483% |
| Rallybio Corporation | -150 Thousand USD | 159900.0% |
| GRI Bio, Inc. | 10.84 Million USD | -2111.051% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -9337.06% |
| Omeros Corporation | -69.77 Million USD | 443.513% |
| INmune Bio, Inc. | 155 Thousand USD | -154545.161% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -286.994% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16013.26% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 37064.843% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 818915.331% |
| Humacyte, Inc. | -76.55 Million USD | 413.129% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 76681.47% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -153.756% |
| Immunocore Holdings plc | 248.39 Million USD | 3.499% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1680.196% |
| Verastem, Inc. | -62 Thousand USD | 386712.903% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 91939.08% |
| Histogen Inc. | 3.76 Million USD | -6259.777% |
| Surrozen, Inc. | -27.23 Million USD | 980.279% |
| Blueprint Medicines Corporation | 236.58 Million USD | -1.317% |
| Organovo Holdings, Inc. | -5.38 Million USD | 4547.95% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | -756 Thousand USD | 31806.349% |
| MEI Pharma, Inc. | 49.32 Million USD | -385.941% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -3851.258% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 357163.056% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 16909.257% |
| Summit Therapeutics Inc. | -2.05 Million USD | 11792.683% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 5095.832% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -724.987% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -164303.292% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1352.199% |
| Pulmatrix, Inc. | -8.22 Million USD | 3016.058% |
| Synaptogenix, Inc. | -6347.00 USD | 3776687.364% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 470100.0% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -48.545% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 60175.188% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 160.106% |
| Cytokinetics, Incorporated | -322.59 Million USD | 174.304% |
| Exelixis, Inc. | 1.75 Billion USD | 86.363% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 313.711% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 29.1% |
| Evogene Ltd. | 1.39 Million USD | -17033.667% |
| Replimune Group, Inc. | -2.65 Million USD | 9128.249% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 418234.878% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 21733.574% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 202393.845% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | -21533.574% |
| Avid Bioservices, Inc. | 7.31 Million USD | -3175.485% |
| Insmed Incorporated | 239.63 Million USD | -0.027% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -48226.613% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 17357.019% |
| Sagimet Biosciences Inc. | 2 Million USD | -11885.0% |
| MediWound Ltd. | 3.57 Million USD | -6599.273% |
| MiMedx Group, Inc. | 266.84 Million USD | 10.172% |
| OmniAb, Inc. | 14.66 Million USD | -1534.281% |
| Alector, Inc. | -95.05 Million USD | 352.175% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -90.812% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 72.522% |
| Mereo BioPharma Group plc | 7.42 Million USD | -3127.848% |
| Zai Lab Limited | 170.9 Million USD | -40.255% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -192.756% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1997600.0% |
| Aura Biosciences, Inc. | -1.29 Million USD | 18609.653% |
| Immunic, Inc. | -111 Thousand USD | 216045.946% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 9839.943% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1411.921% |
| Veracyte, Inc. | 248.14 Million USD | 3.404% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.43% |
| FibroGen, Inc. | 128.9 Million USD | -85.952% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Allakos Inc. | -6.14 Million USD | 4003.273% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2350.419% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 447.411% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 49.632% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 42500100.0% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2101257.083% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 2154.533% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 32.544% |
| Precigen, Inc. | 106 Thousand USD | -226032.075% |
| Fortrea Holdings Inc. | 424 Million USD | 43.467% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 378.181% |
| Incyte Corporation | 3.44 Billion USD | 93.033% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 472508.356% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1520.251% |
| XBiotech Inc. | -1.74 Million USD | 13844.266% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1823.756% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 21733.574% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | 0.521% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 826651.724% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 615.806% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 417.341% |
| Agenus Inc. | 139.61 Million USD | -71.686% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 6052.267% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -226.553% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1326.531% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 38.387% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 582.809% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -123007.422% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 26.641% |
| UroGen Pharma Ltd. | 73.35 Million USD | -226.78% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2216.773% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 997.955% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -4438788.889% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 126925.397% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 358787.357% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -5817.058% |
| Chimerix, Inc. | 324 Thousand USD | -73881.481% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 45757.143% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 542554.965% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 108572.827% |
| Pluri Inc. | 322 Thousand USD | -74340.994% |
| Cue Biopharma, Inc. | -32.6 Million USD | 835.118% |
| MeiraGTx Holdings plc | 287 Thousand USD | -83419.164% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -41501.655% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 12106160.606% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -284.245% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2394.887% |
| CalciMedica, Inc. | -58 Thousand USD | 413375.862% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 8528.27% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 876.608% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 20587.179% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2101257.083% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -8536.017% |
| Nutriband Inc. | 862.1 Thousand USD | -27704.038% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 70393.255% |
| Vor Biopharma Inc. | -3.49 Million USD | 6964.261% |
| Roivant Sciences Ltd. | 109.23 Million USD | -119.435% |
| ProKidney Corp. | -3.16 Million USD | 7663.9% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 645.864% |
| Daré Bioscience, Inc. | 2.76 Million USD | -8554.923% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3395.698% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 13963.505% |
| Bicycle Therapeutics plc | -129.52 Million USD | 285.068% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 404.687% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 726463.636% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 159.975% |
| Atai Life Sciences N.V. | -5000.00 USD | 4794100.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 196802.747% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 249787.5% |
| MediciNova, Inc. | 979.7 Thousand USD | -24366.549% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 384.278% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 253603.252% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1256.811% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -322.841% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 1.977% |
| Biomea Fusion, Inc. | -4.2 Million USD | 5805.784% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | -3.73 Million USD | 6522.83% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 77422.581% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4794100.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 413.854% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -12.148% |
| bluebird bio, Inc. | -4.03 Million USD | 6047.891% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 25572.901% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -23656.194% |
| Imunon, Inc. | -720 Thousand USD | 33391.435% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 87.413% |
| BioAtla, Inc. | -103.73 Million USD | 331.078% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 198.716% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 77173.955% |
| DBV Technologies S.A. | 15.72 Million USD | -1424.034% |
| Fortress Biotech, Inc. | 57.85 Million USD | -314.326% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 232.133% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 442.013% |
| aTyr Pharma, Inc. | -2.38 Million USD | 10137.688% |
| Viridian Therapeutics, Inc. | -1 Million USD | 23879.762% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1843846053.846% |
| Galecto, Inc. | -830 Thousand USD | 28979.518% |
| Akari Therapeutics, Plc | -4000.00 USD | 5992600.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 62.364% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -21320.912% |
| Entera Bio Ltd. | -56 Thousand USD | 428135.714% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -79.164% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 42078.984% |
| Xencor, Inc. | -85.26 Million USD | 381.14% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -9212.354% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 709.257% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 24040.41% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -34.781% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -123007.422% |
| Portage Biotech Inc. | -54 Thousand USD | 443988.889% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 253603.252% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 63680.902% |
| OncoCyte Corporation | 413 Thousand USD | -57938.741% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 107973072.973% |
| Purple Biotech Ltd. | -196 Thousand USD | 122395.918% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2572.837% |
| Onconetix, Inc. | -1.12 Million USD | 21365.742% |
| MacroGenics, Inc. | 50.52 Million USD | -374.4% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1597673.98% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 35983.234% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1158.73% |
| Prime Medicine, Inc. | -147.9 Million USD | 262.063% |
| Aditxt, Inc. | -111.66 Thousand USD | 214769.533% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 3193477.173% |
| Savara Inc. | -44.26 Million USD | 641.548% |
| Curis, Inc. | 9.81 Million USD | -2343.176% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 192185.777% |
| Adagene Inc. | 18.11 Million USD | -1223.469% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 105231.579% |
| BeiGene, Ltd. | 2.07 Billion USD | 88.47% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -39259.606% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 167370.291% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -70.968% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 849557.793% |
| SciSparc Ltd. | 2.19 Million USD | -10815.301% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 849557.793% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 26296.721% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 957024.428% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 773775.037% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2894.004% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -338.858% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 44820.149% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 84.208% |
| ADMA Biologics, Inc. | 88.21 Million USD | -171.713% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -118.362% |
| Clene Inc. | 533 Thousand USD | -44871.857% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 315.697% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 6780.602% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 25147.022% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -11957.344% |
| Adicet Bio, Inc. | -6.09 Million USD | 4030.797% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -381.277% |
| Absci Corporation | -41.84 Million USD | 672.774% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -49018.852% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -51.866% |
| Surrozen, Inc. | -27.23 Million USD | 980.279% |
| Generation Bio Co. | -73.91 Million USD | 424.309% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 408.9% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 54951.259% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 611.753% |
| Invivyd, Inc. | -2.02 Million USD | 11919.527% |
| Cingulate Inc. | -582.91 Thousand USD | 41220.707% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 179.677% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 231833.019% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 3166546.499% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -148.734% |
| Jaguar Health, Inc. | 7.72 Million USD | -3003.314% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -143.875% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -2945.356% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 27307.719% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 64.787% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -894.227% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 123455.771% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 1.37 Million USD | -17370.845% |
| Innoviva, Inc. | 261.06 Million USD | 8.184% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 546.652% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -722.891% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 28772.249% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -187.358% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -327753.157% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -350.886% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 238.405% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 68003.683% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 773325.806% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1316.813% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 24361.134% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 425537.507% |
| AlloVir, Inc. | -398 Thousand USD | 60326.131% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 23326.744% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 23.583% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 82189.041% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 36199.398% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -5873.087% |
| ImmunityBio, Inc. | -17.89 Million USD | 1439.855% |
| Korro Bio, Inc. | -3.63 Million USD | 6703.306% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 347.241% |
| Kineta, Inc. | 5.43 Million USD | -4311.927% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 137194.422% |
| BioVie Inc. | -229.37 Thousand USD | 104600.451% |
| Codexis, Inc. | 57.33 Million USD | -318.077% |
| Celularity Inc. | 6.75 Million USD | -3448.483% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 64190.909% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -473709.053% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1023.806% |
| Cibus, Inc. | 1.42 Million USD | -16756.54% |
| Annexon, Inc. | -3.26 Million USD | 7437.006% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 674.311% |
| Moderna, Inc. | 2.15 Billion USD | 88.877% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 69.211% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 11827.006% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -37353.125% |
| Immix Biopharma, Inc. | -5468.00 USD | 4383786.906% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -38.591% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 3952.459% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -130.262% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 12715.789% |
| Alkermes plc | 1.37 Billion USD | 82.563% |
| Arcellx, Inc. | 108.27 Million USD | -121.373% |
| Moolec Science SA | -143.3 Thousand USD | 167365.622% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 840.523% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -7192.364% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -202.636% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1233.226% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 441.989% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 12782.54% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 6636312.625% |
| Humacyte, Inc. | -76.55 Million USD | 413.129% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 666.426% |
| Geron Corporation | -123.5 Million USD | 294.084% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -5375.103% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 1.79 Billion USD | 86.638% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -103490.892% |
| Notable Labs, Ltd. | 113 Thousand USD | -212023.894% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 315.144% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 25353.536% |
| IN8bio, Inc. | -2.5 Million USD | 9684.166% |
| 89bio, Inc. | -273 Thousand USD | 87902.198% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 799100.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -12773.255% |
| Acasti Pharma Inc. | -11 Thousand USD | 2179190.909% |
| Genelux Corporation | -848 Thousand USD | 28366.509% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 194978.049% |
| Liquidia Corporation | 14.6 Million USD | -1541.781% |
| Mustang Bio, Inc. | -2.22 Million USD | 10873.034% |
| Immunovant, Inc. | -231 Thousand USD | 103866.234% |
| Vericel Corporation | 135.57 Million USD | -76.801% |
| Quantum-Si incorporated | 488 Thousand USD | -49018.852% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 531.433% |
| XOMA Corporation | 3.86 Million USD | -6108.236% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1296.347% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 117245.692% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 37064.843% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 22418.436% |
| Vaxcyte, Inc. | -75 Million USD | 419.6% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 243.094% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 63013.386% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1190.19% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -251.848% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 12342.084% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 28806.587% |
| PepGen Inc. | -1.18 Million USD | 20344.932% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 188840.157% |
| United Therapeutics Corporation | 2.07 Billion USD | 88.42% |
| Solid Biosciences Inc. | -76.56 Million USD | 413.076% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 290353.442% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | 31468.679% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -361634.879% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 6180.596% |
| Belite Bio, Inc | -399 Thousand USD | 60175.188% |
| Pharming Group N.V. | 220.1 Million USD | -8.903% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | -434.44 Thousand USD | 55273.334% |
| Pyxis Oncology, Inc. | -2 Million USD | 12085.0% |
| uniQure N.V. | 2.21 Million USD | -10721.67% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 292417.073% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1256.811% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 360.348% |
| Altimmune, Inc. | -65.37 Million USD | 466.665% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 22418.436% |
| Peak Bio, Inc. | 367.76 Thousand USD | -65076.782% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 54951.259% |
| Benitec Biopharma Inc. | 108 Thousand USD | -221844.444% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 33.79% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2384937.33% |
| Compugen Ltd. | 31.45 Million USD | -662.041% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -21026.761% |
| argenx SE | 1.1 Billion USD | 78.376% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -877.729% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1146.862% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 307407.692% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 20025.187% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 45583.871% |
| PolyPid Ltd. | -1.82 Million USD | 13255.873% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 201528.571% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 5117.794% |
| Forte Biosciences, Inc. | -9000.00 USD | 2663433.333% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -9600.526% |
| Instil Bio, Inc. | -4.75 Million USD | 5139.95% |
| Elevation Oncology, Inc. | -39 Thousand USD | 614715.385% |
| Immunome, Inc. | -8.9 Million USD | 2791.142% |
| Verona Pharma plc | -679.62 Thousand USD | 35369.502% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 58845.68% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 137071.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 10150.314% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 10058.455% |
| Design Therapeutics, Inc. | -537 Thousand USD | 44736.872% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 56235.831% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -11069.618% |
| Achilles Therapeutics plc | -4.73 Million USD | 5166.296% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -557341.86% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 29260.584% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1821805.426% |
| Beam Therapeutics Inc. | -59.67 Million USD | 501.696% |
| Moolec Science SA | -143.3 Thousand USD | 167365.622% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 4794100.0% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1012.555% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 80807.071% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2605.75% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1602.415% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 9072.393% |
| Athira Pharma, Inc. | -969 Thousand USD | 24836.842% |
| HCW Biologics Inc. | -574.82 Thousand USD | 41799.72% |
| XOMA Corporation | 3.86 Million USD | -6108.236% |
| NeurAxis, Inc. | 2.15 Million USD | -11014.182% |
| Lumos Pharma, Inc. | 2 Million USD | -11843.199% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 137071.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 226927.537% |
| Nektar Therapeutics | 53.47 Million USD | -348.222% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 20025.187% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -657.137% |
| Arvinas, Inc. | 71.8 Million USD | -233.844% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Palisade Bio, Inc. | 246 Thousand USD | -97339.024% |
| Nutriband Inc. | 862.1 Thousand USD | -27704.038% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 626.258% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 726463.636% |
| Merus N.V. | -83.46 Million USD | 387.2% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 481.84% |
| Neurogene Inc. | -3.26 Million USD | 7448.253% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -72.031% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 435918.182% |
| CervoMed Inc. | -1.29 Million USD | 18629.298% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 6592.416% |
| Sesen Bio, Inc. | 40 Million USD | -499.25% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 74540.994% |
| Rezolute, Inc. | -36 Thousand USD | 665933.333% |
| Clene Inc. | 533 Thousand USD | -44871.857% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 18668324.299% |
| BeyondSpring Inc. | 1.75 Million USD | -13589.32% |
| Synlogic, Inc. | -1.92 Million USD | 12558.42% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 647937.838% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 3885.534% |
| Peak Bio, Inc. | 367.76 Thousand USD | -65076.782% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1364.04% |
| Krystal Biotech, Inc. | 47.6 Million USD | -403.519% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -69.89% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -4670.149% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 9357.618% |
| MannKind Corporation | 136.19 Million USD | -76.003% |
| Ikena Oncology, Inc. | -50.49 Million USD | 574.729% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -120.284% |
| Gossamer Bio, Inc. | -4.38 Million USD | 5566.363% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 95219.048% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4794100.0% |
| Legend Biotech Corporation | 140.92 Million USD | -70.086% |
| Mural Oncology plc | -2.56 Million USD | 9437.748% |
| Disc Medicine, Inc. | -100 Thousand USD | 239800.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1054.958% |
| REGENXBIO Inc. | 53.02 Million USD | -352.017% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 4574.559% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 124700.39% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 13939.492% |
| Vaxart, Inc. | -60.76 Million USD | 494.483% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 91316.988% |
| Cellectis S.A. | 18 Thousand USD | -1331566.667% |
| Longeveron Inc. | 221 Thousand USD | -108361.538% |
| Repare Therapeutics Inc. | -80.07 Million USD | 399.363% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 78.069% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 18623.957% |
| Revolution Medicines, Inc. | -399.66 Million USD | 159.975% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 684957.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -489083.673% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 97.215% |
| Denali Therapeutics Inc. | -93.34 Million USD | 356.789% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 957024.428% |
| Veru Inc. | 7.56 Million USD | -3068.151% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 158841.722% |
| Cingulate Inc. | -582.91 Thousand USD | 41220.707% |
| Passage Bio, Inc. | -3.72 Million USD | 6541.817% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1990302.591% |
| Exicure, Inc. | -1.42 Million USD | 16944.694% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 62684.856% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -8767.925% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 46854.767% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 160319.776% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 504.858% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -61204.348% |
| OmniAb, Inc. | 14.66 Million USD | -1534.281% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1098.92% |
| Lipocine Inc. | -2.85 Million USD | 8508.113% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 13105.969% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 4301.578% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16013.26% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -218.259% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 368869.231% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -184.355% |
| Ocugen, Inc. | -33.53 Million USD | 814.733% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 7680.645% |
| Q32 Bio Inc. | 578 Thousand USD | -41370.588% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 90552.83% |
| Alumis Inc. Common Stock | -1.28 Million USD | 18768.224% |
| Equillium, Inc. | 35.95 Million USD | -566.611% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 14142.179% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -47774.986% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 5798358.345% |
| Dominari Holdings Inc. | 2.03 Million USD | -11655.763% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 130747.35% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1863.148% |
| Bio-Techne Corporation | 773.07 Million USD | 68.994% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1284.029% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 47.98% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 20604.705% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1099.583% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1949.243% |
| Nkarta, Inc. | -5.86 Million USD | 4184.171% |
| BioCardia, Inc. | -7.24 Million USD | 3406.663% |
| Iterum Therapeutics plc | -1.75 Million USD | 13797.143% |